Valantin MA - Search Results

1

High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2.

Pourcher V, Belin L, Soulie C, Rosenzwajg M, Marot S, Lacombe K, Valin N, Pialoux G, Calin R, Palacios C, Malet I, Zafilaza K, Tubiana R, Valantin MA, Klatzmann D, Calvez V, Simon-Tillaux N, Marcelin AG. Pourcher V, et al. Among authors: valantin ma. AIDS. 2022 Sep 1;36(11):1545-1552. doi: 10.1097/QAD.0000000000003300. Epub 2022 Jun 22. AIDS. 2022. PMID: 35730380

2

[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].

Mouroux M, Bossi P, Yvon-Groussin A, Delaugerre C, Valantin MA, Tubiana R, Coutellier A, Bonmarchand M, Bricaire F, Katlama C, Agut H, Huraux JM, Calvez V. Mouroux M, et al. Among authors: valantin ma. Pathol Biol (Paris). 1999 May;47(5):549-52. Pathol Biol (Paris). 1999. PMID: 10418038 French.

3

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.

Delaugerre C, Valantin MA, Mouroux M, Bonmarchand M, Carcelain G, Duvivier C, Tubiana R, Simon A, Bricaire F, Agut H, Autran B, Katlama C, Calvez V. Delaugerre C, et al. Among authors: valantin ma. AIDS. 2001 Nov 9;15(16):2189-91. doi: 10.1097/00002030-200111090-00016. AIDS. 2001. PMID: 11684940 Clinical Trial.

4

Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.

Mouroux M, Descamps D, Izopet J, Yvon A, Delaugerre C, Matheron S, Coutellier A, Valantin MA, Bonmarchand M, Agut H, Massip P, Costagliola D, Katlama C, Brun-Vezinet F, Calvez V. Mouroux M, et al. Among authors: valantin ma. Antivir Ther. 2001 Sep;6(3):179-83. Antivir Ther. 2001. PMID: 11808752

5

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.

Calvez V, Costagliola D, Descamps D, Yvon A, Collin G, Cécile A, Delaugerre C, Damond F, Marcelin AG, Matheron S, Simon A, Valantin MA, Katlama C, Brun-Vézinet F. Calvez V, et al. Among authors: valantin ma. Antivir Ther. 2002 Sep;7(3):211-8. Antivir Ther. 2002. PMID: 12487389

6

Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, Bousquet R, Katz P, Costagliola D, Katlama C. Valantin MA, et al. AIDS. 2003 Nov 21;17(17):2471-7. doi: 10.1097/00002030-200311210-00009. AIDS. 2003. PMID: 14600518

7

Acute hepatitis C in HIV-infected men who have sex with men.

Ghosn J, Pierre-François S, Thibault V, Duvivier C, Tubiana R, Simon A, Valantin MA, Dominguez S, Caumes E, Katlama C. Ghosn J, et al. Among authors: valantin ma. HIV Med. 2004 Jul;5(4):303-6. doi: 10.1111/j.1468-1293.2004.00225.x. HIV Med. 2004. PMID: 15236621 Free article.

8

MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study.

Katlama C, Ghosn J, Tubiana R, Wirden M, Valantin MA, Harmenberg J, Mårdh G, Oberg B, Calvez V. Katlama C, et al. Among authors: valantin ma. AIDS. 2004 Jun 18;18(9):1299-304. doi: 10.1097/00002030-200406180-00008. AIDS. 2004. PMID: 15362662 Clinical Trial.

9

Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.

Wirden M, Marcelin AG, Simon A, Kirstetter M, Tubiana R, Valantin MA, Paris L, Bonmarchand M, Conan F, Kalkias L, Katlama C, Calvez V. Wirden M, et al. Among authors: valantin ma. J Med Virol. 2005 Jul;76(3):297-301. doi: 10.1002/jmv.20359. J Med Virol. 2005. PMID: 15902696

10

Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors.

Roquebert B, Malet I, Wirden M, Tubiana R, Valantin MA, Simon A, Katlama C, Peytavin G, Calvez V, Marcelin AG. Roquebert B, et al. Among authors: valantin ma. AIDS. 2006 Jan 9;20(2):287-9. doi: 10.1097/01.aids.0000202650.03279.69. AIDS. 2006. PMID: 16511425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters